September 10, 2012 – The statement provides expanded indications for cardiac resynchronization therapy (CRT) in an effort to clarify which patients are most likely to benefit from CRT. Additional updates include guidance regarding the frequency of in-person and remote monitoring of patients with cardiovascular implantable electronic devices.
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay supersedes the pacemaker recommendations made in this 2012 Focused Update and 2008 guidelines.
Topic
- Clinical Topics
- Device Therapy
Resource Type
- Clinical Documents
Related Resources

Clinical Documents
18F-FDG PET/CT and Radiolabeled Leukocyte SPECT/CT Imaging for the Evaluation of Cardiovascular Infection in the Multimodality Context
The American Society of Nuclear Cardiology (ASNC) and Heart Rhythm Society (HRS), in partnership with 9 other societies, have released a consensus statement on the…
March 11, 2024

Clinical Documents
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation
The American College of Cardiology (ACC) and American Heart Association (AHA) released updated recommendations for preventing and managing atrial fibrillation. The new guideline was developed…
November 30, 2023

Clinical Documents
2003 NASPE Training Requirements for Cardiac Implantable Electronic Devices: Selection, Implantation, and Follow-Up
This statement provides additional information regarding maintenance of skills related to device implantation, more detailed training guidelines for CIED implantation and lead extraction, and initial…
July 1, 2023